| Covance Inc. announced that it entered into a biomarker alliance and services agreement with Rules-Based Medicine, Inc., or RBM, a leading provider of multiplexed protein biomarker testing to the pharmaceutical industry. Subject to the terms of the agreement, Covance will use RBM as its exclusive third-party provider of multiplexed protein biomarker testing services, and RBM will use Covance as its exclusive referral source for laboratory testing services. :theflyonthewall.com |